Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

A Zumla, M Rao, RS Wallis, SHE Kaufmann… - The Lancet Infectious …, 2016 - thelancet.com
Despite extensive global efforts in the fight against killer infectious diseases, they still cause
one in four deaths worldwide and are important causes of long-term functional disability …

Microbiome-immune interactions in tuberculosis

G Mori, M Morrison, A Blumenthal - PLoS pathogens, 2021 - journals.plos.org
Tuberculosis (TB) remains an infectious disease of global significance and a leading cause
of death in low-and middle-income countries. Significant effort has been directed towards …

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Y Huang, L Zhang, S Karuna, P Andrew… - Nature …, 2023 - nature.com
Broadly neutralizing monoclonal antibodies (mAbs) are being developed for HIV-1
prevention. Hence, these mAbs and licensed oral pre-exposure prophylaxis (PrEP)(tenofovir …

Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV …

S Ravimohan, N Tamuhla, AP Steenhoff… - The Lancet Infectious …, 2015 - thelancet.com
Background Patients co-infected with advanced HIV and tuberculosis are at risk of
tuberculosis-associated immune reconstitution inflammatory syndrome (IRIS) and death …

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis

A Zumla, M Rao, E Dodoo, M Maeurer - BMC medicine, 2016 - Springer
Abstract Treatment of multidrug-resistant tuberculosis (MDR-TB) is extremely challenging
due to the virulence of the etiologic strains of Mycobacterium tuberculosis (M. tb), the …

Immune reconstitution inflammatory syndrome associated with pulmonary pathogens

R Gopal, RR Rapaka, JK Kolls - European Respiratory Review, 2017 - Eur Respiratory Soc
Immune reconstitution inflammatory syndrome (IRIS) is an exaggerated immune response to
a variety of pathogens in response to antiretroviral therapy-mediated recovery of the immune …

Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated …

S Ravimohan, N Tamuhla, K Nfanyana… - Clinical Infectious …, 2016 - academic.oup.com
Background. The immunopathogenesis of paradoxical tuberculosis-associated immune
reconstitution inflammatory syndrome (TB-IRIS) remains unclear. We determined the …

Atorvastatin reduces T‐cell activation and exhaustion among HIV‐infected c ART‐treated suboptimal immune responders in U ganda: a randomised crossover …

D Nakanjako, I Ssinabulya, R Nabatanzi… - Tropical medicine & …, 2015 - Wiley Online Library
Objective T‐cell activation independently predicts mortality, poor immune recovery and non‐
AIDS illnesses during combination antiretroviral therapy (c ART). Atorvastatin showed anti …

TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB

V Haridas, P Pean, LD Jasenosky, Y Madec… - Aids, 2015 - journals.lww.com
Objective: To investigate the impact of tuberculosis-associated immune reconstitution
inflammatory syndrome (TB-IRIS) upon immunological recovery and the T-cell compartment …

Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment

CC Chang, V Sheikh, I Sereti, MA French - Current HIV/AIDS Reports, 2014 - Springer
An immune reconstitution disorder occurs in up to 40% of severely immunodeficient HIV
patients who commence antiretroviral therapy (ART), with an immune reconstitution …